Skip to main content

Research Repository

Advanced Search

Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders?

Corsetti, Maura; Pannemans, Jasper; Whorwell, Peter

Authors

Jasper Pannemans

Peter Whorwell



Abstract

Opioids have recently received much attention because of the epidemic in their use in some countries such as the USA and the UK. Concerns have been raised about the possibility that they can increase mortality in patients when used on a long-term basis. Moreover, they are known to induce paradoxical hyperalgesia as well as alterations of gut function. The analgesic properties of opioids are mediated by receptors located in the brain, but as opioid receptors are also expressed in the gastrointestinal tract, new drugs acting on these receptors have recently been developed to treat two functional disorders, namely irritable bowel syndrome with diarrhoea and opioid-induced constipation. The aim of this article is to highlight some interesting observations resulting from the development of these drugs in the field of functional gastrointestinal disorders.

Journal Article Type Article
Publication Date Mar 5, 2019
Journal F1000Research
Print ISSN 2046-1402
Electronic ISSN 1759-796X
Publisher F1000Research
Peer Reviewed Peer Reviewed
Volume 8
Article Number 257
APA6 Citation Corsetti, M., Pannemans, J., & Whorwell, P. (2019). Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders?. F1000Research, 8, https://doi.org/10.12688/f1000research.15974.1
DOI https://doi.org/10.12688/f1000research.15974.1
Keywords Opioids; Mu opioid receptors; PAMORA; Eluxadoline
Publisher URL https://f1000research.com/articles/8-257/v1
Additional Information Referee status: Indexed; Referee Report: 10.5256/f1000research.17446.r44837, Klaus Bielefeldt, Gastroenterology Section, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA, 05 Mar 2019, version 1, indexed; Referee Report: 10.5256/f1000research.17446.r44836, Eamonn Quigley, Houston Methodist Hospital, Houston, TX, USA, 05 Mar 2019, version 1, indexed; Grant Information: The author(s) declared that no grants were involved in supporting this work; Copyright: This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

Files





You might also like



Downloadable Citations

;